Cem Somer ATABEKOĞLU, Batuhan ÖZMEN, Batuhan TURGAY, Murat SÖNMEZER, Ruşen AYTAÇ, Bülent BERKER, Yavuz Emre ŞÜKÜR

Does different subfertility etiology affect pregnancy rates in intrauterine insemination cycles?

Background/aim: To investigate the relationship between subfertility etiologies and success rates in controlled ovarian stimulation andintrauterine insemination (COS–IUI) cycles.Materials and methods: The medical records of 218 couples who applied to a university-based fertility center were analyzedretrospectively. Detailed infertility examination data and pregnancy outcomes were compared according to different subfertilityetiologies. The study groups with regard to subfertility etiologies were minimal–mild endometriosis, unexplained infertility, and mildmale infertility. The primary outcome measure was live birth rate.Results: There were no statistically significant differences between the groups regarding demographics except for total motile spermcount. Live birth rates in the male infertility group were comparable to the endometriosis and unexpected infertility groups (6.6%,11.9%, and 10.3%, respectively; P = 0.63).Conclusion: The success rate of the mild male subfertility group following COS–IUI cycles for live birth rates was similar to those of theendometriosis and unexplained subfertility groups.

PDF

___

1. Stephen EH, Chandra A. Declining estimates of infertility in the United States: 1982–2002. Fertility and Sterility 2006; 86(3): 516-523. doi: 10.1016/j.fertnstert.2006.02.129
2. Dickey RP, Pyrzak R, Lu PY, Taylor SN, Rye PH. Comparison of the sperm quality necessary for successful intrauterine insemination with World Health Organization threshold values for normal sperm. Fertility and Sterility 1999; 71(4): 684-689. doi: 10.1016/s0015-0282(98)00519-6
3. Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G et al. ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group. ESHRE guidelines for the diagnosis and treatment of endometriosis. Human Reproduction 2005; 20(10): 2698-2704. doi: 10.1093/ humrep/dei135
4. Practice Committee of the American Society for Reproductive Medicine. Effectiveness and treatment for unexplained infertility. Fertility and Sterility 2006; 86(5 Suppl 1): S111-S114. doi: 10.1016/j.fertnstert.2006.07.1475
5. Francavilla F, Sciarretta F, Sorgentone S, Necozione S, Santucci R et al. Intrauterine insemination with or without mild ovarian stimulation in couples with male subfertility due to oligo/ astheno- and/or teratozoospermia or antisperm antibodies: a prospective cross-over trial. Fertility and Sterility 2009; 92(3): 1009-1011. doi: 10.1016/j.fertnstert.2009.01.112
6. Hull MG. Effectiveness of infertility treatments: choice and comparative analysis. International Journal of Gynecology and Obstetrics 1994; 47(2): 99-108. doi: 10.1016/0020- 7292(94)90348-4
7. Diamond MP, Legro RS, Coutifaris C, Alvero R, Robinson RD et al. Letrozole, gonadotropin, or clomiphene for unexplained infertility. The New England Journal of Medicine 2015; 373(13): 1230-1240. doi: 10.1056/NEJMoa1414827
8. Veltman-Verhulst SM, Hughes E, Ayeleke RO, Cohlen BJ. Intra-uterine insemination for unexplained subfertility. Cochrane Database Systematic Review 2016; 19; 2:CD001838. doi: 10.1002/14651858.CD001838.pub5
9. The European IVF-monitoring Consortium (EIM). European Society of Human Reproduction and Embryology (ESHRE), Calhaz-Jorge C, De Geyter C, Kupka MS, de Mouzon J, Erb K et al. Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE. Human Reproduction 2017; 32(10): 1957-1973. doi: 10.1093/humrep/ dex264
10. Guzick, DS, Overstreet JW, Factor-Litvak P, Brazil CK, Nakajima ST et al. Sperm morphology, motility, and concentration in fertile and infertile men. The New England Journal of Medicine 2001; 345(19): 1388-1393. doi: 10.1056/ NEJMoa003005
11. Van Voorhis BJ, Barnett M, Sparks AE, Syrop CH, Rosenthal G et al. Effect of the total motile sperm count on the efficacy and cost-effectiveness of intrauterine insemination and in vitro fertilization. Fertility and Sterility 2001; 75(4): 661-668. doi: 10.1016/s0015-0282(00)01783-0
12. Cohlen BJ. Should we continue performing intrauterine insemination in the year 2004? Gynecologic and Obstetric Investigation 2005; 59(1): 3-13. doi:10.1159/000080492
13. Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Human Reproduction 2005; 20(10): 2698-2704. doi: 10.1093/humrep/dei135
14. Cissen M, Bensdorp A, Cohlen BJ, Repping S, de Bruin JP et al. Assisted reproductive technologies for male subfertility. Cochrane Database Systematic Review 2016; 2:CD000360. doi: 10.1002/14651858.CD000360.pub5
15. Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertility and Sterility 2015; 103(3): e9-e17. doi: 10.1016/j.fertnstert.2014.12.093
16. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Human Reproduction Update 2006; 12(6): 685-718. doi: 10.1093/humupd/dml034
17. Berker B, Kahraman K, Taskin S, Sukur YE, Sonmezer M et al. Recombinant FSH versus clomiphene citrate for ovarian stimulation in couples with unexplained infertility and male subfertility undergoing intrauterine insemination: a randomized trial. Archives of Gynecology and Obstetrics 2011; 284(6): 1561-1566. doi: 10.1007/s00404-011-1997-4
18. Goverde AJ, McDonnell J, Vermeiden JP, Schats R, Rutten FF et al. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet 2000; 355(9197): 13-18. doi: 10.1016/S0140-6736(99)04002-7
19. Bensdorp AJ, Cohlen BJ, Heineman MJ, Vandekerckhove P. Intra-uterine insemination for male subfertility. Cochrane Database Systematic Review 2007; 18(3): CD000360. doi: 10.1002/14651858.CD000360.pub4
20. Bhattacharya S, Harrild K, Mollison J, Wordsworth S, Tay C et al. Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial. British Medical Journal 2008; 337: a716. doi: 10.1136/bmj.a716
21. Wordsworth S, Buchanan J, Mollison J, Harrild K, Robertson L. et al. Clomifene citrate and intrauterine insemination as first-line treatments for unexplained infertility: are they cost effective? Human Reproduction 2011; 26(2): 369-375. doi: 10.1093/humrep/deq315
22. Veltman-Verhulst SM, Cohlen BJ, Hughes E, Heineman MJ. Intra-uterine insemination for unexplained subfertility. Cochrane Database Systematic Review 2012; 9: CD001838. doi: 10.1002/14651858.CD001838.pub4
23. Sicchieri F, Silva AB, Silva ACJSRE, Navarro PAAS, Ferriani RA et al. Prognostic factors in intrauterine insemination cycles. JBRA Assisted Reproduction 2018; 22(1): 02-07. doi: 10.5935/1518-0557.20180002
24. Werbrouck E, Spiessens C, Meuleman C, D’Hooghe T. No difference in cycle pregnancy rate and in cumulative livebirth rate between women with surgically treated minimal to mild endometriosis and women with unexplained infertility after controlled ovarian hyperstimulation and intrauterine insemination. Fertility and Sterility 2006; 86(3): 566-571. doi: 10.1016/j.fertnstert.2006.01.044
25. Prado-Perez J, Perez-Rivadeneira E, Sanon-Julien F. The impact of endometriosis on the rate of pregnancy of patients submitted to intrauterine insemination. Fertility and Sterility 2002; 77: S51. doi: 10.1016/S0015-0282(01)03182-X
26. Ghaffari F, Sadatmahalleh SJ, Akhoond MR, Eftekhari Yazdi P, Zolfaghari Z. Evaluating the effective factors in pregnancy after intrauterine insemination: A retrospective study. International Journal of Fertility and Sterility 2015; 9(3): 300-308. doi: 10.22074/ijfs.2015.4544
27. Wu HM, Tzeng CR, Chen CH, Chen PH. Pelvic endometriosis with peritoneal fluid reduces pregnancy rates in women undergoing intrauterine insemination. Taiwanese Journal of Obstetrics and Gynecology 2013; 52(4): 512-515. doi: 10.1016/j.tjog.2013.10.010
28. Duffy JM, Arambage K, Correa FJ, Olive D, Farquhar C et al. Laparoscopic surgery for endometriosis. Cochrane Database Systematic Review 2014; 4: CD011031. doi: 10.1002/14651858. CD011031.pub2
29. Miller DC, Hollenbeck BK, Smith GD, Randolph JF, Christman GM et al. Processed total motile sperm count correlates with pregnancy outcome after intra-uterine insemination. Urology 2002; 60(3): 497-501. doi: 10.1016/s0090-4295(02)01773-9
30. Patel P, Carrasquillo R, Madhusoodanan V, Dadoun S, Patel A et al. Impact of abnormal sperm morphology on live birth rates following intrauterine insemination. Journal of Urology 2019; 101097JU0000000000000288. doi: 10.1097/ JU.0000000000000288
31. Cohlen B, Bijkerk A, Van der Poel S, Ombelet W. IUI: review and systematic assessment of the evidence that supports global recommendations. Human Reproduction Update 2018; 24(3): 300-319. doi: 10.1093/humupd/dmx041